APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dupilumab Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dupilumab Drug Market Analysis and Forecast 2026-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchDupilumab Drug Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Dupilumab Drug Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Dupilumab Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dupilumab Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Dupilumab Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dupilumab Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dupilumab Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dupilumab Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dupilumab Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dupilumab Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dupilumab Drug include Sanofi, Swixx Biopharma, Amicus Llc and ABACUS MEDICINE, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dupilumab Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dupilumab Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Dupilumab Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dupilumab Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dupilumab Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dupilumab Drug sales, projected growth trends, production technology, application and end-user industry.

Dupilumab Drug Segment by Company

Sanofi

Swixx Biopharma

Amicus Llc

ABACUS MEDICINE

Dupilumab Drug Segment by Type

200mg (1.14mL)/Vial

300mg (2.0 mL)/Vial

Dupilumab Drug Segment by Application

Hospitals

Retail Pharmacy

Others

Dupilumab Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dupilumab Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dupilumab Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dupilumab Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dupilumab Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dupilumab Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dupilumab Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dupilumab Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 200mg (1.14mL)/Vial Major Manufacturers Table 3. 300mg (2.0 mL)/Vial Major Manufacturers Table 4. Global Dupilumab Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Retail Pharmacy Major Manufacturers Table 7. Others Major Manufacturers Table 8. Dupilumab Drug Industry Trends Table 9. Dupilumab Drug Industry Drivers Table 10. Dupilumab Drug Industry Opportunities and Challenges Table 11. Dupilumab Drug Industry Restraints Table 12. Global Dupilumab Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dupilumab Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dupilumab Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dupilumab Drug Revenue Market Share by Region (2021-2026) Table 16. Global Dupilumab Drug Revenue Market Share by Region (2027-2032) Table 17. Global Dupilumab Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Dupilumab Drug Sales by Region (2021-2026) & (k units) Table 19. Global Dupilumab Drug Sales by Region (2027-2032) & (k units) Table 20. Global Dupilumab Drug Sales Market Share by Region (2021-2026) Table 21. Global Dupilumab Drug Sales Market Share by Region (2027-2032) Table 22. Global Dupilumab Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dupilumab Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dupilumab Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dupilumab Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dupilumab Drug Sales Price (USD/unit) of Manufacturers (2021-2026) Table 27. Global Dupilumab Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dupilumab Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dupilumab Drug Manufacturers, Product Type & Application Table 30. Global Dupilumab Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dupilumab Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dupilumab Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dupilumab Drug Revenue Market Share by Type (2021-2026) Table 37. Global Dupilumab Drug Revenue Market Share by Type (2027-2032) Table 38. Global Dupilumab Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 40. Global Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 41. Global Dupilumab Drug Sales Market Share by Type (2021-2026) Table 42. Global Dupilumab Drug Sales Market Share by Type (2027-2032) Table 43. Global Dupilumab Drug Price by Type (2021-2026) & (USD/unit) Table 44. Global Dupilumab Drug Price by Type (2027-2032) & (USD/unit) Table 45. Global Dupilumab Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dupilumab Drug Revenue Market Share by Application (2021-2026) Table 49. Global Dupilumab Drug Revenue Market Share by Application (2027-2032) Table 50. Global Dupilumab Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 52. Global Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 53. Global Dupilumab Drug Sales Market Share by Application (2021-2026) Table 54. Global Dupilumab Drug Sales Market Share by Application (2027-2032) Table 55. Global Dupilumab Drug Price by Application (2021-2026) & (USD/unit) Table 56. Global Dupilumab Drug Price by Application (2027-2032) & (USD/unit) Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Dupilumab Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 60. Sanofi Dupilumab Drug Product Portfolio Table 61. Sanofi Recent Development Table 62. Swixx Biopharma Company Information Table 63. Swixx Biopharma Business Overview Table 64. Swixx Biopharma Dupilumab Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 65. Swixx Biopharma Dupilumab Drug Product Portfolio Table 66. Swixx Biopharma Recent Development Table 67. Amicus Llc Company Information Table 68. Amicus Llc Business Overview Table 69. Amicus Llc Dupilumab Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Amicus Llc Dupilumab Drug Product Portfolio Table 71. Amicus Llc Recent Development Table 72. ABACUS MEDICINE Company Information Table 73. ABACUS MEDICINE Business Overview Table 74. ABACUS MEDICINE Dupilumab Drug Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. ABACUS MEDICINE Dupilumab Drug Product Portfolio Table 76. ABACUS MEDICINE Recent Development Table 77. North America Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 78. North America Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 79. North America Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 80. North America Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 81. North America Dupilumab Drug Sales Price by Type (2021-2026) & (USD/unit) Table 82. North America Dupilumab Drug Sales Price by Type (2027-2032) & (USD/unit) Table 83. North America Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 84. North America Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 85. North America Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 86. North America Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 87. North America Dupilumab Drug Sales Price by Application (2021-2026) & (USD/unit) Table 88. North America Dupilumab Drug Sales Price by Application (2027-2032) & (USD/unit) Table 89. North America Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Dupilumab Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 91. North America Dupilumab Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 92. North America Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 93. North America Dupilumab Drug Sales by Country (2021-2026) & (k units) Table 94. North America Dupilumab Drug Sales by Country (2027-2032) & (k units) Table 95. North America Dupilumab Drug Sales Price by Country (2021-2026) & (USD/unit) Table 96. North America Dupilumab Drug Sales Price by Country (2027-2032) & (USD/unit) Table 97. United States Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 98. Canada Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 99. Mexico Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 100. Europe Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 103. Europe Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 104. Europe Dupilumab Drug Sales Price by Type (2021-2026) & (USD/unit) Table 105. Europe Dupilumab Drug Sales Price by Type (2027-2032) & (USD/unit) Table 106. Europe Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 107. Europe Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 108. Europe Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 109. Europe Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 110. Europe Dupilumab Drug Sales Price by Application (2021-2026) & (USD/unit) Table 111. Europe Dupilumab Drug Sales Price by Application (2027-2032) & (USD/unit) Table 112. Europe Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Dupilumab Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 114. Europe Dupilumab Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 115. Europe Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 116. Europe Dupilumab Drug Sales by Country (2021-2026) & (k units) Table 117. Europe Dupilumab Drug Sales by Country (2027-2032) & (k units) Table 118. Europe Dupilumab Drug Sales Price by Country (2021-2026) & (USD/unit) Table 119. Europe Dupilumab Drug Sales Price by Country (2027-2032) & (USD/unit) Table 120. Germany Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 121. France Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 122. U.K. Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 123. Italy Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 124. Russia Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 125. Spain Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 127. Switzerland Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 128. Sweden Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 129. Poland Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 130. China Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. China Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. China Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 133. China Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 134. China Dupilumab Drug Sales Price by Type (2021-2026) & (USD/unit) Table 135. China Dupilumab Drug Sales Price by Type (2027-2032) & (USD/unit) Table 136. China Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. China Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. China Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 139. China Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 140. China Dupilumab Drug Sales Price by Application (2021-2026) & (USD/unit) Table 141. China Dupilumab Drug Sales Price by Application (2027-2032) & (USD/unit) Table 142. Asia Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 145. Asia Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 146. Asia Dupilumab Drug Sales Price by Type (2021-2026) & (USD/unit) Table 147. Asia Dupilumab Drug Sales Price by Type (2027-2032) & (USD/unit) Table 148. Asia Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 149. Asia Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 150. Asia Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 151. Asia Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 152. Asia Dupilumab Drug Sales Price by Application (2021-2026) & (USD/unit) Table 153. Asia Dupilumab Drug Sales Price by Application (2027-2032) & (USD/unit) Table 154. Asia Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Asia Dupilumab Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Asia Dupilumab Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Asia Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 158. Asia Dupilumab Drug Sales by Country (2021-2026) & (k units) Table 159. Asia Dupilumab Drug Sales by Country (2027-2032) & (k units) Table 160. Asia Dupilumab Drug Sales Price by Country (2021-2026) & (USD/unit) Table 161. Asia Dupilumab Drug Sales Price by Country (2027-2032) & (USD/unit) Table 162. Japan Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 163. South Korea Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 164. India Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 165. Australia Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 166. Taiwan Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 167. Southeast Asia Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 168. SAMEA Dupilumab Drug Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Dupilumab Drug Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Dupilumab Drug Sales by Type (2021-2026) & (k units) Table 171. SAMEA Dupilumab Drug Sales by Type (2027-2032) & (k units) Table 172. SAMEA Dupilumab Drug Sales Price by Type (2021-2026) & (USD/unit) Table 173. SAMEA Dupilumab Drug Sales Price by Type (2027-2032) & (USD/unit) Table 174. SAMEA Dupilumab Drug Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Dupilumab Drug Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Dupilumab Drug Sales by Application (2021-2026) & (k units) Table 177. SAMEA Dupilumab Drug Sales by Application (2027-2032) & (k units) Table 178. SAMEA Dupilumab Drug Sales Price by Application (2021-2026) & (USD/unit) Table 179. SAMEA Dupilumab Drug Sales Price by Application (2027-2032) & (USD/unit) Table 180. SAMEA Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. SAMEA Dupilumab Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. SAMEA Dupilumab Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. SAMEA Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. SAMEA Dupilumab Drug Sales by Country (2021-2026) & (k units) Table 185. SAMEA Dupilumab Drug Sales by Country (2027-2032) & (k units) Table 186. SAMEA Dupilumab Drug Sales Price by Country (2021-2026) & (USD/unit) Table 187. SAMEA Dupilumab Drug Sales Price by Country (2027-2032) & (USD/unit) Table 188. Brazil Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 189. Argentina Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 190. Chile Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 191. Colombia Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 192. Peru Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 193. Saudi Arabia Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 194. Israel Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 195. UAE Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 196. Turkey Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 197. Iran Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 198. Egypt Dupilumab Drug Revenue (2021-2032) & (US$ Million) Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Dupilumab Drug Distributors List Table 202. Dupilumab Drug Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Dupilumab Drug Image Figure 2. Global Dupilumab Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dupilumab Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 200mg (1.14mL)/Vial Image Figure 5. 300mg (2.0 mL)/Vial Image Figure 6. Global Dupilumab Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dupilumab Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Retail Pharmacy Image Figure 10. Others Image Figure 11. Global Dupilumab Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dupilumab Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Dupilumab Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dupilumab Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dupilumab Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Dupilumab Drug Sales (2021-2032) & (k units) Figure 17. Global Dupilumab Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Dupilumab Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dupilumab Drug Sales YoY (2021-2032) & (k units) Figure 20. Europe Dupilumab Drug Sales YoY (2021-2032) & (k units) Figure 21. China Dupilumab Drug Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Dupilumab Drug Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Dupilumab Drug Sales YoY (2021-2032) & (k units) Figure 24. Global Dupilumab Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dupilumab Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dupilumab Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dupilumab Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dupilumab Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Dupilumab Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Dupilumab Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dupilumab Drug Sales Market Share by Type (2021-2032) Figure 33. Global Dupilumab Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dupilumab Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dupilumab Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Dupilumab Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Dupilumab Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dupilumab Drug Sales Market Share by Application (2021-2032) Figure 39. North America Dupilumab Drug Revenue Share by Type (2021-2032) Figure 40. North America Dupilumab Drug Sales Share by Type (2021-2032) Figure 41. North America Dupilumab Drug Revenue Share by Application (2021-2032) Figure 42. North America Dupilumab Drug Sales Share by Application (2021-2032) Figure 43. North America Dupilumab Drug Revenue Share by Country (2021-2032) Figure 44. North America Dupilumab Drug Sales Share by Country (2021-2032) Figure 45. Europe Dupilumab Drug Revenue Share by Type (2021-2032) Figure 46. Europe Dupilumab Drug Sales Share by Type (2021-2032) Figure 47. Europe Dupilumab Drug Revenue Share by Application (2021-2032) Figure 48. Europe Dupilumab Drug Sales Share by Application (2021-2032) Figure 49. Europe Dupilumab Drug Revenue Share by Country (2021-2032) Figure 50. Europe Dupilumab Drug Sales Share by Country (2021-2032) Figure 51. China Dupilumab Drug Revenue Share by Type (2021-2032) Figure 52. China Dupilumab Drug Sales Share by Type (2021-2032) Figure 53. China Dupilumab Drug Revenue Share by Application (2021-2032) Figure 54. China Dupilumab Drug Sales Share by Application (2021-2032) Figure 55. Asia Dupilumab Drug Revenue Share by Type (2021-2032) Figure 56. Asia Dupilumab Drug Sales Share by Type (2021-2032) Figure 57. Asia Dupilumab Drug Revenue Share by Application (2021-2032) Figure 58. Asia Dupilumab Drug Sales Share by Application (2021-2032) Figure 59. Asia Dupilumab Drug Revenue Share by Country (2021-2032) Figure 60. Asia Dupilumab Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Dupilumab Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Dupilumab Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Dupilumab Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Dupilumab Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Dupilumab Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Dupilumab Drug Sales Share by Country (2021-2032) Figure 67. Dupilumab Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dupilumab Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 200mg (1.14mL)/Vial
  • 300mg (2.0 mL)/Vial
Applications
  • Hospitals
  • Retail Pharmacy
  • Others
Companies covered
  • Sanofi
  • Swixx Biopharma
  • Amicus Llc
  • ABACUS MEDICINE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dupilumab Drug Market by Type
  3. 1.2.1 Global Dupilumab Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 200mg (1.14mL)/Vial
  5. 1.2.3 300mg (2.0 mL)/Vial
  6. 1.3 Dupilumab Drug Market by Application
  7. 1.3.1 Global Dupilumab Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Retail Pharmacy
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dupilumab Drug Market Dynamics
  1. 2.1 Dupilumab Drug Industry Trends
  2. 2.2 Dupilumab Drug Industry Drivers
  3. 2.3 Dupilumab Drug Industry Opportunities and Challenges
  4. 2.4 Dupilumab Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dupilumab Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dupilumab Drug Revenue by Region
  3. 3.2.1 Global Dupilumab Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dupilumab Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Dupilumab Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Dupilumab Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dupilumab Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dupilumab Drug Sales by Region
  9. 3.4.1 Global Dupilumab Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dupilumab Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Dupilumab Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Dupilumab Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dupilumab Drug Revenue by Manufacturers
  2. 4.1.1 Global Dupilumab Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dupilumab Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dupilumab Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dupilumab Drug Sales by Manufacturers
  6. 4.2.1 Global Dupilumab Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dupilumab Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dupilumab Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dupilumab Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dupilumab Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dupilumab Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dupilumab Drug Manufacturers, Product Type & Application
  13. 4.7 Global Dupilumab Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dupilumab Drug Market CR5 and HHI
  16. 4.8.2 2025 Dupilumab Drug Tier 1, Tier 2, and Tier 3
5 Dupilumab Drug Market by Type
  1. 5.1 Global Dupilumab Drug Revenue by Type
  2. 5.1.1 Global Dupilumab Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dupilumab Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dupilumab Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dupilumab Drug Sales by Type
  6. 5.2.1 Global Dupilumab Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dupilumab Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Dupilumab Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dupilumab Drug Price by Type
6 Dupilumab Drug Market by Application
  1. 6.1 Global Dupilumab Drug Revenue by Application
  2. 6.1.1 Global Dupilumab Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dupilumab Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dupilumab Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dupilumab Drug Sales by Application
  6. 6.2.1 Global Dupilumab Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dupilumab Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Dupilumab Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dupilumab Drug Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Dupilumab Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Dupilumab Drug Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Swixx Biopharma
  8. 7.2.1 Swixx Biopharma Company Information
  9. 7.2.2 Swixx Biopharma Business Overview
  10. 7.2.3 Swixx Biopharma Dupilumab Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Swixx Biopharma Dupilumab Drug Product Portfolio
  12. 7.2.5 Swixx Biopharma Recent Developments
  13. 7.3 Amicus Llc
  14. 7.3.1 Amicus Llc Company Information
  15. 7.3.2 Amicus Llc Business Overview
  16. 7.3.3 Amicus Llc Dupilumab Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amicus Llc Dupilumab Drug Product Portfolio
  18. 7.3.5 Amicus Llc Recent Developments
  19. 7.4 ABACUS MEDICINE
  20. 7.4.1 ABACUS MEDICINE Company Information
  21. 7.4.2 ABACUS MEDICINE Business Overview
  22. 7.4.3 ABACUS MEDICINE Dupilumab Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 ABACUS MEDICINE Dupilumab Drug Product Portfolio
  24. 7.4.5 ABACUS MEDICINE Recent Developments
8 North America
  1. 8.1 North America Dupilumab Drug Market Size by Type
  2. 8.1.1 North America Dupilumab Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Dupilumab Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Dupilumab Drug Price by Type (2021-2032)
  5. 8.2 North America Dupilumab Drug Market Size by Application
  6. 8.2.1 North America Dupilumab Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Dupilumab Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Dupilumab Drug Price by Application (2021-2032)
  9. 8.3 North America Dupilumab Drug Market Size by Country
  10. 8.3.1 North America Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dupilumab Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dupilumab Drug Market Size by Type
  2. 9.1.1 Europe Dupilumab Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dupilumab Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Dupilumab Drug Price by Type (2021-2032)
  5. 9.2 Europe Dupilumab Drug Market Size by Application
  6. 9.2.1 Europe Dupilumab Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dupilumab Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Dupilumab Drug Price by Application (2021-2032)
  9. 9.3 Europe Dupilumab Drug Market Size by Country
  10. 9.3.1 Europe Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dupilumab Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dupilumab Drug Market Size by Type
  2. 10.1.1 China Dupilumab Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Dupilumab Drug Sales by Type (2021-2032)
  4. 10.1.3 China Dupilumab Drug Price by Type (2021-2032)
  5. 10.2 China Dupilumab Drug Market Size by Application
  6. 10.2.1 China Dupilumab Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Dupilumab Drug Sales by Application (2021-2032)
  8. 10.2.3 China Dupilumab Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dupilumab Drug Market Size by Type
  2. 11.1.1 Asia Dupilumab Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dupilumab Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Dupilumab Drug Price by Type (2021-2032)
  5. 11.2 Asia Dupilumab Drug Market Size by Application
  6. 11.2.1 Asia Dupilumab Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dupilumab Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Dupilumab Drug Price by Application (2021-2032)
  9. 11.3 Asia Dupilumab Drug Market Size by Country
  10. 11.3.1 Asia Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dupilumab Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dupilumab Drug Market Size by Type
  2. 12.1.1 SAMEA Dupilumab Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dupilumab Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dupilumab Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Dupilumab Drug Market Size by Application
  6. 12.2.1 SAMEA Dupilumab Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dupilumab Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dupilumab Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Dupilumab Drug Market Size by Country
  10. 12.3.1 SAMEA Dupilumab Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dupilumab Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dupilumab Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dupilumab Drug Value Chain Analysis
  2. 13.1.1 Dupilumab Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dupilumab Drug Production Mode & Process
  6. 13.2 Dupilumab Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dupilumab Drug Distributors
  9. 13.2.3 Dupilumab Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst